Aclo, Rica Mae M.
HRN: 28-58-33 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2026
CO-AMOXICLAV 625MG (TAB)
07/18/2026
07/25/2026
PO
625mg
BID X 7 Days
S/P NSVD With RMLE; UTI
Checking Final Appropriateness